Search Results - "Czaplinski, A"

Refine Results
  1. 1

    A case report on concomitant reversible cerebral vasoconstriction syndrome and transient global amnesia by Maibach, F., Czaplinski, A., Peters, N., Paliantonis, A.

    Published in Cortex (01-03-2024)
    “…Reversible Cerebral Vasoconstriction Syndrome clinically presents as severe headaches with or without neurological deficits accompanied by multilocal caliber…”
    Get full text
    Journal Article
  2. 2

    Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population by Czaplinski, A, Yen, A A, Appel, S H

    “…In a large cohort of 1034 patients with the diagnosis of definite or probable amyotrophic lateral sclerosis (ALS), the association of forced vital capacity…”
    Get full text
    Journal Article
  3. 3

    Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis by Kuhle, J., Lindberg, R. L. P., Regeniter, A., Mehling, M., Steck, A. J., Kappos, L., Czaplinski, A.

    Published in European journal of neurology (01-06-2009)
    “…Background and purpose:  Amyotrophic lateral sclerosis (ALS) is classically assumed to be a neurodegenerative disorder. Inflammation has been observed in CNS…”
    Get full text
    Journal Article
  4. 4

    Real‐life long‐term effectiveness of fingolimod in Swiss patients with relapsing‐remitting multiple sclerosis by Zecca, C., Roth, S., Findling, O., Perriard, G., Bachmann, V., Pless, M. L., Baumann, A., Kamm, C. P., Lalive, P. H., Czaplinski, A.

    Published in European journal of neurology (01-05-2018)
    “…Background and purpose In 2011, fingolimod was approved in Switzerland for the treatment of relapsing‐remitting multiple sclerosis (RRMS). The aim of the…”
    Get full text
    Journal Article
  5. 5

    Posterior reversible encephalopathy as the initial manifestation of a Guillain–Barré syndrome by Sutter, R, Mengiardi, B, Lyrer, P, Czaplinski, A

    Published in Neuromuscular disorders : NMD (01-10-2009)
    “…Abstract We report a female patient with posterior reversible encephalopathy syndrome as the initial manifestation of a Guillain–Barré syndrome. She presented…”
    Get full text
    Journal Article
  6. 6

    Reconsidering clinical outcomes in Multiple Sclerosis: Relapses, impairment, disability and beyond by D'Souza, M, Kappos, L, Czaplinski, A

    Published in Journal of the neurological sciences (15-11-2008)
    “…Abstract There is an increasing number of clinical trials testing new compounds which act at different stages of Multiple Sclerosis (MS). To prove their…”
    Get full text
    Journal Article Conference Proceeding
  7. 7
  8. 8
  9. 9
  10. 10

    The value of database controls in pilot or futility studies in ALS by CZAPLINSKI, A, HAVERKAMP, L. J, YEN, A. A, SIMPSON, E. P, LAI, E. C, APPEL, S. H

    Published in Neurology (28-11-2006)
    “…To evaluate the use and reliability of database controls in place of a placebo group in pilot or "futility" ALS trials. We compared the rates of disease…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Flail arm syndrome: a clinical variant of amyotrophic lateral sclerosis by Czaplinski, A., Steck, A. J., Andersen, P. M., Weber, M.

    Published in European journal of neurology (01-08-2004)
    “…We describe a case of a 65‐year old patient diagnosed with amyotrophic lateral sclerosis. The clinical findings, with symmetric, predominantly proximal wasting…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Moving to wellness: a pilot study examining a nurse-driven exercise program in acutely ill patients with cancer by McLaughlin, Teresa Money, Wittstein, Emma Rondares, White, Teresa H, Czaplinski, Cindy A, Gerard, Sally O'Toole

    Published in Clinical journal of oncology nursing (01-06-2012)
    “…Preventing patients with cancer from falling is a particularly important strategy for avoiding serious patient harm. Patients with cancer often fall as a…”
    Get full text
    Journal Article
  16. 16

    IgM deposits on skin nerves in anti-myelin-associated glycoprotein neuropathy by Lombardi, Raffaella, Erne, Beat, Lauria, Giuseppe, Pareyson, Davide, Borgna, Monica, Morbin, Michela, Arnold, Andreas, Czaplinski, Adam, Fuhr, Peter, Schaeren-Wiemers, Nicole, Steck, Andreas J.

    Published in Annals of neurology (01-02-2005)
    “…Anti–myelin‐associated glycoprotein (anti‐MAG) neuropathy is a chronic demyelinating neuropathy with predominant involvement of large sensory fibers and…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Specific aspects of immunotherapy for multiple sclerosis in Switzerland: A structured commentary by Achtnichts, L, Chan, A, Czaplinski, A, Derfuss, T, Du Pasquier, R, Findling, O, Gobbi, C, Hoepner, R, Kamber, N, Kamm, CP, Kuhle, J, Lalive, P, Lutterotti, A, Martin, R, Müller, S, Papadopoulou, A, Pot, C, Salmen, A, Schippling, S, Zecca, C

    Published in Clinical and translational neuroscience (01-01-2019)
    “…More than a dozen substances are meanwhile available for the disease-modifying immunotherapy of multiple sclerosis (MS). However, for some substances, there is…”
    Get full text
    Journal Article
  19. 19

    Immune mediated neuropathies: An update on therapeutic strategies by CZAPLINSKI, Adam, STECK, Andreas J

    Published in Journal of neurology (01-02-2004)
    “…This paper reviews recent treatment strategies of immune mediated neuropathies, in particular it includes data regarding Guillain-Barré syndrome (GBS), chronic…”
    Get full text
    Journal Article
  20. 20

    A case report on concomitant reversible cerebral vasoconstriction syndrome and transient global amnesia by Maibach, F, Czaplinski, A, Peters, N, Paliantonis, A

    “…Reversible Cerebral Vasoconstriction Syndrome clinically presents as severe headaches with or without neurological deficits accompanied by multilocal caliber…”
    Get full text
    Report